What is SigTuple?
Headquartered in Bengaluru, India, and founded in 2015, SigTuple is at the forefront of developing intelligent screening solutions that leverage artificial intelligence to analyze visual medical data. The company's technology aims to revolutionize medical diagnosis by providing AI-powered insights, thereby improving accuracy and efficiency in healthcare. SigTuple's focus on AI in medical imaging positions it as a key player in the rapidly evolving health-tech sector, addressing critical needs in diagnostic pathways.
How much funding has SigTuple raised?
SigTuple has raised a total of $52.1M across 4 funding rounds:
Series A
$5.8M
Series B
$19M
Series C
$23.3M
Series C
$4M
Series A (2017): $5.8M with participation from Pi Ventures, Axilor Ventures, IDG Capital, Accel Partners, and Endiya Partners
Series B (2018): $19M led by Accel, Endiya Partners, Venture Highway, pi Ventures, Binny Bansal, Axilor Ventures, Ridge Ventures, and Trifecta Capital Services
Series C (2023): $23.3M supported by Trifecta Capital Services, Accel Partners, Binny Bansal, Trusted Insights, Pi Ventures, Chiratae Ventures, and Endiya Partners
Series C (2024): $4M featuring SIDBI Venture Capital and Endiya Partners
Key Investors in SigTuple
Accel
Accel is a venture capital firm known for investing in early-stage and growth-stage companies. They have a strong focus on technology and innovation, providing strategic capital and operational support to help portfolio companies scale.
Endiya Partners
Endiya Partners is an early-stage venture capital fund that focuses on investing in Indian product startups within the sectors of enterprise, industrial technology, healthcare, and life sciences. The firm aims to support entrepreneurs with innovative, market-creating business models and strong fundamentals, helping them build scalable companies with regional and global potential.
pi Ventures
Pi Ventures is a venture capital firm that focuses its investments in companies developing artificial intelligence, machine learning, and IoT technologies. Founded in 2016 and based in Bangalore, India, it supports innovative tech startups.
What's next for SigTuple?
The substantial enterprise-level funding and recent strategic investment indicate SigTuple is poised for significant scaling and further technological development. This capital infusion will likely fuel expansion into new markets, enhance research and development efforts for its AI diagnostic tools, and strengthen its position within the global healthcare technology landscape. The company's trajectory suggests a move towards broader adoption of its solutions, potentially impacting diagnostic workflows across various medical specialties.
See full SigTuple company page
